SXTC icon

China SXT Pharmaceuticals

6 hedge funds and large institutions have $390K invested in China SXT Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 4 closing their positions.

Holders
6
Holders Change
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
Reduced
2
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
HF
1
HRT Financial
New York
$176K 95,500 +95,500 New
Citadel Advisors
2
Citadel Advisors
Florida
$99K 53,418 +53,418 New
Geode Capital Management
3
Geode Capital Management
Massachusetts
$49K 26,642 -79,926 -75%
Goldman Sachs
4
Goldman Sachs
New York
$49K 26,408 +26,408 New
UBS Group
5
UBS Group
Switzerland
$16K 8,523 -46,661 -85%
Royal Bank of Canada
6
Royal Bank of Canada
Ontario, Canada
$1K 625 +625 New
Renaissance Technologies
7
Renaissance Technologies
New York
-664,647 Closed
Susquehanna International Group
8
Susquehanna International Group
Pennsylvania
-18,443 Closed
HI
9
Hudock Inc
Pennsylvania
-7,500 Closed
Fifth Third Bancorp
10
Fifth Third Bancorp
Ohio
-1,000 Closed
CFGS
11
Concourse Financial Group Securities
Alabama